Views & Analysis | Perspectives on pharma industry issues

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Market Access

Biotech's next growth cycle: Renewed confidence comes with c...

Renewed confidence across biopharma is welcome and long overdue after a prolonged period of constraint. But confidence alone is not enough.

Oncology

The future of oncology is adaptive: What ESMO 2026 revealed ...

Across tumours, three developments repeatedly surfaced throughout the congress, each reflecting a notable transition in how cancer is being managed.

Market Access

Sponsored

Solution Spotlight: Acumetis Model Builder

Acumetis Model Builder is a web-based platform that generates complete, formula-linked Excel cost-effectiveness and budget impact models in minutes.

Articles

Tunnah’s musings: 9.63 seconds

In Paul Tunnah’s latest musings he reminisces on the many great images from the 2012 London Olympics and the inspiration they provide for pharma and healthcare. You can sense the collective hangover dawning on people now that the 2012 Olympic Games have finally drawn to a close. For the past few weeks London has…

Articles

Pharma gets social: was Facebook page responsible for K-V Ph...

Following K-V Pharma’s recent filing for bankruptcy, Daniel Ghinn takes a look at the part social media played and shares his thoughts on just how important it is for pharma companies to have a social media strategy in place. “WOOT! I feel bad celebrating anyone losing needed jobs, but this company has to GO... what they tried to do to women...

Articles

Realising the potential of stratified medicine

Bob Damms and Hakim Yadi discuss the potential of stratified medicine – the first step towards personalised medicines. The potential of stratified medicine has long been talked about, but the pace of development has increased dramatically...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Digital